Department of Rehabilitation Sciences, Belgian Road Safety Institute, Brussels, Belgium.
Neurology. 2012 Nov 6;79(19):1975-82. doi: 10.1212/WNL.0b013e3182735d11. Epub 2012 Oct 24.
To identify the most accurate clinical predictors of fitness to drive (FTDr) in Huntington disease (HD).
This cross-sectional study included 60 active drivers: 30 patients with manifest HD (8 women) and 30 age- and gender-matched healthy controls. Mean (SD) age of the HD group was 50 (12) years and median (Q1-Q3) disease duration was 24 (12-48) months. A clinical battery consisting of a driving history questionnaire, the cognitive section of the Unified Huntington's Disease Rating Scale (UHDRS), Trail Making Test, and Mini-Mental State Examination, as well as a driving simulator evaluation, were administered to all participants. Additionally, the subjects with HD completed the motor, behavioral, and Total Functional Capacity sections of the UHDRS and underwent an official FTDr evaluation comprising visual, neuropsychological, and on-road tests. The blinded neurologist's appraisal of FTDr and the 3 most predictive clinical tests were compared with the official pass/fail FTDr decision.
The patients with HD performed worse on all tests of the clinical battery and driving simulator than the healthy controls. Fifteen patients with HD (50) failed the FTDr evaluation. The blinded neurologist correctly classified 21 patients (70%). The Symbol Digit Modalities Test, Stroop word reading, and Trail Making Test B provided the best model (R(2) = 0.49) to predict FTDr, correctly classifying 26 patients (87%).
Half of active drivers with HD fail a driving evaluation and pose a potential hazard on the road. Our results suggest that those at risk can be accurately identified using a clinical screening tool.
确定亨廷顿病(HD)患者驾驶适应性(FTDr)最准确的临床预测指标。
本横断面研究纳入 60 名活跃驾驶员:30 名有症状的 HD 患者(8 名女性)和 30 名年龄和性别匹配的健康对照者。HD 组的平均(SD)年龄为 50(12)岁,中位(Q1-Q3)病程为 24(12-48)个月。所有参与者均接受了临床电池测试,包括驾驶史问卷、统一亨廷顿病评定量表(UHDRS)认知部分、连线测试和简易精神状态检查,以及驾驶模拟器评估。此外,HD 患者还完成了 UHDRS 的运动、行为和总功能能力部分,以及包括视觉、神经心理学和道路测试在内的官方 FTDr 评估。盲法神经科医生对 FTDr 的评估和 3 个最具预测性的临床测试与官方通过/失败的 FTDr 决策进行了比较。
HD 患者在临床电池和驾驶模拟器的所有测试中表现均比健康对照组差。15 名 HD 患者(50%)未能通过 FTDr 评估。盲法神经科医生正确分类了 21 名患者(70%)。符号数字模态测试、Stroop 文字阅读和连线测试 B 提供了最佳的模型(R²=0.49),可预测 FTDr,正确分类了 26 名患者(87%)。
一半的活跃 HD 驾驶员未能通过驾驶评估,对道路构成潜在危险。我们的结果表明,可以使用临床筛查工具准确识别那些有风险的患者。